
Madrigal Pharmaceuticals Inc is a biotechnology business based in the US. Madrigal Pharmaceuticals shares (MDGL) are listed on the NASDAQ and all prices are listed in US Dollars. Madrigal Pharmaceuticals employs 71 staff and has a market cap (total outstanding shares value) of 0.00.
How to buy shares in Madrigal Pharmaceuticals
- Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
- Open your brokerage account. Complete an application with your details.
- Confirm your payment details. Fund your account.
- Research the stock. Find the stock by name or ticker symbol – MDGL – and research it before deciding if it's a good investment for you.
- Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
- Check in on your investment. Optimize your portfolio by tracking your stock.
Our top pick for
Beginners

Our top pick for
Building a portfolio

Our top pick for
Advanced traders

Madrigal Pharmaceuticals stock price (NASDAQ: MDGL)
Use our graph to track the performance of MDGL stocks over time.Madrigal Pharmaceuticals shares at a glance
Latest market close | $71.58 |
---|---|
52-week range | $52.33 - $105.93 |
50-day moving average | $70.58 |
200-day moving average | $80.20 |
Wall St. target price | $160.58 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-14.65 |
Buy Madrigal Pharmaceuticals shares from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.*Signup bonus information updated weekly.
The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.
Is it a good time to buy Madrigal Pharmaceuticals stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Madrigal Pharmaceuticals price performance over time
Historical closes compared with the close of $71.58 from 2022-06-30
1 week (2022-06-24) | -14.23% |
---|---|
1 month (2022-06-01) | 8.36% |
3 months (2022-04-01) | -28.56% |
6 months (2021-12-29) | -13.19% |
1 year (2021-07-01) | -27.97% |
---|---|
2 years (2020-07-01) | -36.23% |
3 years (2019-07-01) | 106.53 |
5 years (2017-06-30) | 340.22% |
Madrigal Pharmaceuticals financials
Gross profit TTM | $0 |
---|---|
Return on assets TTM | -58.01% |
Return on equity TTM | -121.5% |
Profit margin | 0% |
Book value | $8.52 |
Market capitalisation | $1.5 billion |
TTM: trailing 12 months
Madrigal Pharmaceuticals share dividends
We're not expecting Madrigal Pharmaceuticals to pay a dividend over the next 12 months.
Have Madrigal Pharmaceuticals's shares ever split?
Madrigal Pharmaceuticals's shares were split on a 1:35 basis on 24 July 2016. So if you had owned 35 shares the day before before the split, the next day you'd have owned 1 share. This wouldn't directly have changed the overall worth of your Madrigal Pharmaceuticals shares – just the quantity. However, indirectly, the new 3400% higher share price could have impacted the market appetite for Madrigal Pharmaceuticals shares which in turn could have impacted Madrigal Pharmaceuticals's share price.
Madrigal Pharmaceuticals share price volatility
Over the last 12 months, Madrigal Pharmaceuticals's shares have ranged in value from as little as $52.33 up to $105.93. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Madrigal Pharmaceuticals's is 1.2827. This would suggest that Madrigal Pharmaceuticals's shares are more volatile than the average for this exchange and represent, relatively-speaking, a higher risk (but potentially also market-beating returns).
Madrigal Pharmaceuticals overview
Madrigal Pharmaceuticals, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular, metabolic, and liver diseases. Its lead product candidate is resmetirom, a liver-directed selective thyroid hormone receptor-ß agonist, which is in Phase III clinical trials for the treatment of non-alcoholic steatohepatitis. The company also develops MGL-3745, a backup compound to resmetirom. It has research, development, and commercialization agreement with Hoffmann-La Roche. Madrigal Pharmaceuticals, Inc. is headquartered in West Conshohocken, Pennsylvania.
Madrigal Pharmaceuticals in the news
Analysts Believe Madrigal's Resmetirom Shows Impressive Overall Profile In Liver Fibrosis
Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™
Madrigal Pharmaceuticals Presents Late-Breaking Phase 3 NASH Data and Multiple Oral Abstracts at EASL’s International Liver Congress™
Frequently asked questions
What percentage of Madrigal Pharmaceuticals is owned by insiders or institutions?Currently 18.771% of Madrigal Pharmaceuticals shares are held by insiders and 82.13% by institutions. How many people work for Madrigal Pharmaceuticals?
Latest data suggests 71 work at Madrigal Pharmaceuticals. When does the fiscal year end for Madrigal Pharmaceuticals?
Madrigal Pharmaceuticals's fiscal year ends in December. Where is Madrigal Pharmaceuticals based?
Madrigal Pharmaceuticals's address is: Four Tower Bridge, West Conshohocken, PA, United States, 19428 What is Madrigal Pharmaceuticals's ISIN number?
Madrigal Pharmaceuticals's international securities identification number is: US5588681057 What is Madrigal Pharmaceuticals's CUSIP number?
Madrigal Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 558868105
More guides on Finder
-
How to buy Citrine Global (CTGL) stock when it goes public
Everything we know about the Citrine Global IPO, plus information on how to buy in.
-
How to buy Genelux Corporation (GNLX) stock when it goes public
Everything we know about the Genelux Corporation IPO, plus information on how to buy in.
-
How to buy Magic Empire Global (MEGL) stock when it goes public
Everything we know about the Magic Empire Global IPO, plus information on how to buy in.
-
How to buy Intchains Group (ICG) stock when it goes public
Everything we know about the Intchains Group IPO, plus information on how to buy in.
-
How to buy Biostage (BSTG) stock when it goes public
Everything we know about the Biostage IPO, plus information on how to buy in.
-
How to buy Wang & Lee Group (WLGS) stock when it goes public
Everything we know about the Wang & Lee Group IPO, plus information on how to buy in.
-
How to buy OptMed (OMED) stock when it goes public
Everything we know about the OptMed IPO, plus information on how to buy in.
-
How to buy Lichen China (LICN) stock when it goes public
Everything we know about the Lichen China IPO, plus information on how to buy in.
-
How to buy LeeWay Services stock when it goes public
Everything we know about the LeeWay Services IPO, plus information on how to buy in.
-
How to buy Nano Labs (NA) stock when it goes public
Everything we know about the Nano Labs IPO, plus information on how to buy in.
Ask an Expert